Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISPERIDONE vs RIVAROXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISPERIDONE vs RIVAROXABAN: Safety Overview

Metric RISPERIDONE RIVAROXABAN
Total FAERS Reports 79,288 131,274
Deaths Reported 4,120 19,233
Death Rate 5.2% 14.7%
Hospitalizations 18,771 70,513
Average Patient Age 31.9 yrs 70.0 yrs
% Female Patients 15.6% 47.7%
FDA Approval Date Apr 12, 2007 Apr 10, 2025
Manufacturer NuCare Pharmaceuticals, Inc. Macleods Pharmaceuticals Limited
Route ORAL ORAL
Marketing Status Prescription Prescription